Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
NCT00308373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73
Last updated 2010-01-20
Summary
People with type 2 diabetes mellitus (earlier known as maturity onset diabetes mellitus) have high blood levels of sugar and fat. This study is being done to determine if excessive sugar entering the blood in people with type 2 diabetes mellitus is caused by excessive fat. We will also evaluate how the anti-diabetic medications, pioglitazone and metformin taken by mouth work to control blood sugar in people with diabetes.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Metformin vs Thiazolidinedione (Pioglitazone)
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - lead OTHER
Principal Investigators
-
Robert A. Rizza, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2005-11-30
- Completion
- 2005-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
NCT00067951 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
NCT00727857 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
NCT00499707 ·Status: COMPLETED ·Phase: PHASE3
-
Fatty Liver Study in Patients With Type II Diabetes
NCT02365233 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Thiazolidinedione Treatment Vascular Risk Markers
NCT00571506 ·Status: COMPLETED ·Phase: PHASE4
-
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
NCT00672919 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
NCT05591235 ·Status: UNKNOWN ·Phase: PHASE3
-
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
NCT00609856 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
NCT00770445 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
NCT02678676 ·Status: COMPLETED
-
Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
NCT01040819 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
NCT02027103 ·Status: COMPLETED ·Phase: NA
-
Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
NCT00329225 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety In Poorly Controlled Type 2 Diabetics
NCT00044460 ·Status: COMPLETED ·Phase: PHASE4
-
Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes
NCT00770367 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
NCT00443755 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
NCT00655863 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
NCT01156597 ·Status: COMPLETED ·Phase: PHASE3
-
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
NCT01107717 ·Status: COMPLETED ·Phase: PHASE4
-
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
NCT05838287 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
NCT00970424 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
NCT00770835 ·Status: COMPLETED ·Phase: PHASE4
-
SGLT2i, Pioglitazone, and Ketone Production in T2D
NCT07053319 ·Status: RECRUITING ·Phase: PHASE1
-
Dyslipidemia in Type 2 Diabetes (0767-034)
NCT00547274 ·Status: TERMINATED ·Phase: PHASE3
-
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
NCT01082120 ·Status: COMPLETED ·Phase: PHASE1